Cite
HARVARD Citation
King, M. et al. (2020). Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial. Lancet oncology. 21 (5), pp. 685-698. [Online].